Ozempic cut heavy drinking in clinical study

Health

Ozempic Cut Heavy Drinking In Clinical Study

By POLITICO Europe

The U.S. researchers said the results justify larger clinical trials to evaluate this class of drugs — known as glucagon-like peptide 1 (GLP-1) receptor agonists — for alcohol use disorder. The study is published today in the Journal of the American ...Read more